Semaglutide dosage: reported doses and schedule

Typical reported dose: 0.25 mg once a week to start, up to 2.4 mg

• Ozempic injection: 0.5–2 mg: 0.25 mg once weekly, then 0.5 mg once weekly, then 1 mg once weekly, then 2 mg once weekly once weekly, under the skin. Drug label. Studied in: Adults in the product’s approved population. (source)
• Ozempic: kidney-risk indication: 0.25 mg once weekly, then 0.5 mg once weekly, then 1 mg once weekly once weekly, under the skin. Drug label. Studied in: Adults with diabetes and chronic kidney disease. (source)
• Wegovy: weight maintenance: 0.25 mg once weekly, then 0.5 mg once weekly, then 1 mg once weekly, then 1.7 mg once weekly once weekly, under the skin. Drug label. Studied in: Adults in the product’s approved population. (source)
• Wegovy: cardiovascular risk: 0.25 mg once weekly, then 0.5 mg once weekly, then 1 mg once weekly, then 1.7 mg once weekly once weekly, under the skin. Drug label. Studied in: Adults in the product’s approved population. (source)
• Wegovy: noncirrhotic MASH: 0.25 mg once weekly, then 0.5 mg once weekly, then 1 mg once weekly, then 1.7 mg once weekly once weekly, under the skin. Drug label. Studied in: Adults in the product’s approved population. (source)
• Wegovy: 1.7 mg maintenance: 0.25 mg once weekly, then 0.5 mg once weekly, then 1 mg once weekly, then 1.7 mg once weekly once weekly, under the skin. Drug label. Studied in: Adults in the product’s approved population. (source)

Highest studied: Highest verified human weekly arm: 16 mg nominal, 16.13 mg delivered; approved limits are lower.; Highest verified daily oral efficacy dose: 50 mg; also EU-labeled for diabetes..

These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.

Work out syringe units with the dosing calculator